Fate Therapeutics, Inc.
Fate Therapeutics, Inc. (FATE) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
fate · stock forecast · 31 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 31 Wall Street analysts in the past 3 months
Buy
31 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$7.00
Consensus
$5.50
+188.0% upside
Low
$4.00
Median: $5.5 · Last Close: $1.91
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$5.50
188.0% upside
High Target
$7
266.5%
Low Target
$4
109.4%
Current Price
$1.91
as of today
Based on analyst price targets, the FATE stock price prediction for the next 12 months ranges from $4 to $7. The consensus FATE price forecast of $5.50 implies 188.0% upside from the current price of $1.91.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.91 | ↓ 0.23% |
1-day model range: $1.87–$1.94. Peak: $1.94 (-0.23%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -50.0% |
| 2028 | $1 | -62.5% |
| 2029 | $1 | -67.2% |
| 2030 | $1 | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · FATE · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-31 | HC Wainwright & Co. | Upgrade ↑ | Neutral→Buy |
| 2025-10-27 | Needham | Maintains | Hold→Hold |
| 2025-10-27 | Wedbush | Upgrade ↑ | Neutral→Outperform |
| 2025-08-13 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2025-06-12 | Needham | Maintains | Hold→Hold |
| 2025-05-14 | Baird | Maintains | Neutral→Neutral |
| 2025-05-14 | Needham | Maintains | Hold→Hold |
| 2025-05-14 | Barclays | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Fate Therapeutics, Inc. (FATE) stock. Of the recent 130 rating actions, 9 were upgrades and 14 were downgrades. 31 analysts currently cover FATE.
Analyst Recommendation Trends
FATE analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$5M
↑ 2.6% YoY
Revenue Next Year
$5M
↓ 0.5% YoY
EPS This Year
$-1.08
EPS Next Year
$-0.97
↓ 10.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast FATE EPS of $-1.08 for the current fiscal year, based on estimates from 9 analysts. The FATE revenue forecast is $5M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The FATE stock forecast is supported by two independent data sources: analyst consensus ratings from 31 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus FATE price target is $5.50 (+188.0% upside), with an analyst consensus of Buy.
The FATE short-term stock prediction for tomorrow is $1.91 (-0.23%). The FATE stock price prediction for 2027 estimates an average of $1. The FATE stock prediction for 2030 projects a range of $0–$1.
Fate Therapeutics, Inc. trades on NASDAQ under the ticker FATE. The FATE stock outlook for 2027 is broadly positive, supported by a Buy consensus among 52% of covering analysts.
Frequently asked questions
FATE forecast · 8 questionsAccording to 31 Wall Street analysts, the average 12-month FATE price target is $5.50, with a high forecast of $7.00 and a low of $4.00. The median price target is shown in the chart above when available. This implies +188.0% potential upside from the current price of $1.91.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.